129 related articles for article (PubMed ID: 31749282)
1. DDX49 is a novel biomarker and therapeutic target for lung cancer metastases.
Lian X; Xiang D; Peng C; Chen J; Liao M; Sun G; Zhang Z
J Cell Mol Med; 2020 Jan; 24(1):1141-1145. PubMed ID: 31749282
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG20 promoted proliferation, invasion and inhibited cell apoptosis of lung adenocarcinoma via sponging miR-342 and upregulating DDX49.
Wang X; Gu G; Zhu H; Lu S; Abuduwaili K; Liu C
Thorac Cancer; 2020 Dec; 11(12):3510-3520. PubMed ID: 33089952
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of the model consisting of DDX49, EGFR, and T-stage as a possible risk factor for lymph node metastasis in patients with lung cancer.
Zhang Z; Lian X; Yue H; Xiang D; Niu Z
Thorac Cancer; 2023 Jun; 14(16):1492-1499. PubMed ID: 37096455
[TBL] [Abstract][Full Text] [Related]
4. DDX49 Promotes Proliferation and Metastasis of Cervical Cancer by Regulation of AKT and Wnt/β-Catenin Signalings.
Chen Y; Ma Q; Sun N
Ann Clin Lab Sci; 2023 Mar; 53(2):271-277. PubMed ID: 37094865
[TBL] [Abstract][Full Text] [Related]
5. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
[TBL] [Abstract][Full Text] [Related]
6. Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
Ge Q; Cong P; Ji Y
IUBMB Life; 2019 Nov; 71(11):1806-1814. PubMed ID: 31419016
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of DDX49 in prostate cancer is associated with poor prognosis.
Tao J; Ge Q; Meng J; Liang C; Hao Z; Zhou J
BMC Urol; 2023 Apr; 23(1):66. PubMed ID: 37106339
[TBL] [Abstract][Full Text] [Related]
8. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
9. PYGB Promoted Tumor Progression by Regulating Wnt/β-Catenin Pathway in Gastric Cancer.
Xia B; Zhang K; Liu C
Technol Cancer Res Treat; 2020; 19():1533033820926592. PubMed ID: 32462986
[TBL] [Abstract][Full Text] [Related]
10. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
11. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
[TBL] [Abstract][Full Text] [Related]
12. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
13. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
15. Morphine may act via DDX49 to inhibit hepatocellular carcinoma cell growth.
Dai H; Feng J; Nan Z; Wei L; Lin F; Jin R; Zhang S; Wang X; Pan L
Aging (Albany NY); 2021 May; 13(9):12766-12779. PubMed ID: 33952717
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling.
Wang M; Wang W; Ding J; Wang J; Zhang J
Thorac Cancer; 2020 Feb; 11(2):379-388. PubMed ID: 31841274
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
[TBL] [Abstract][Full Text] [Related]
19. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p.
Li K; Jiang Y; Xiang X; Gong Q; Zhou C; Zhang L; Ma Q; Zhuang L
Thorac Cancer; 2020 May; 11(5):1180-1190. PubMed ID: 32147945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
